Related Experiment Video
Updated: Aug 2, 2025

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.3K
Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening
Tianhui Chen1,2, Elham Kharazmi3,4, Mahdi Fallah3,4,5,6
1Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou, China.
JAMA Network Open
|April 19, 2023
Summary
Black women experience higher breast cancer mortality and may benefit from earlier screening. This study suggests race-adapted screening ages to address disparities in breast cancer (BC) detection and outcomes.
Area of Science:
- Oncology
- Public Health
- Health Disparities
Background:
- Breast cancer (BC) is a leading cause of cancer death in women, with significant racial disparities in mortality, particularly for early-onset BC in Black women.
- Current BC screening guidelines, often recommending a universal starting age of 50, may not be equitable or optimal given these disparities.
Purpose of the Study:
- To determine race and ethnicity-adapted starting ages for breast cancer screening.
- To address current racial and ethnic disparities in BC mortality using population-based data.
Main Methods:
- A nationwide, population-based, cross-sectional study analyzed US female breast cancer mortality data from 2011-2020.
- Risk-adapted starting ages were calculated based on the 10-year cumulative risk of BC-specific death for different racial and ethnic groups.
Main Results:
- Black females reached the 0.329% 10-year cumulative BC death risk threshold at age 42, 8 years earlier than White females (age 51).
- American Indian/Alaska Native and Hispanic females reached this threshold at age 57, while Asian/Pacific Islander females reached it at age 61.
- Race-adapted screening could mean starting mass screening 6-7 years earlier for Black females.
Conclusions:
- This study provides evidence for race-adapted starting ages for breast cancer screening.
- A risk-adapted approach, considering individual race and ethnicity, may improve screening equity and reduce mortality from early-onset BC.

